PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
270.00
-2.00 (-0.74%)
Apr 29, 2026, 9:10 AM WIB
Market Cap340.00B +66.9%
Revenue (ttm)166.62B +2.2%
Net Income2.94B +293.0%
EPS2.35 +293.0%
Shares Out1.25B
PE Ratio115.76
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,800
Average Volume528,470
Open276.00
Previous Close272.00
Day's Range270.00 - 276.00
52-Week Range136.00 - 382.00
Beta0.78
RSI44.47
Earnings DateApr 30, 2026

About IDX:DGNS

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology,... [Read more]

Sector Healthcare
Founded 2007
Employees 111
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DGNS
Full Company Profile

Financial Performance

In 2025, IDX:DGNS's revenue was 166.62 billion, an increase of 2.18% compared to the previous year's 163.07 billion. Earnings were 2.94 billion, an increase of 292.95%.

Financial Statements